272 related articles for article (PubMed ID: 16510332)
1. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.
Theodorescu D; Wittke S; Ross MM; Walden M; Conaway M; Just I; Mischak H; Frierson HF
Lancet Oncol; 2006 Mar; 7(3):230-40. PubMed ID: 16510332
[TBL] [Abstract][Full Text] [Related]
2. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
3. Prediction of muscle-invasive bladder cancer using urinary proteomics.
Schiffer E; Vlahou A; Petrolekas A; Stravodimos K; Tauber R; Geschwend JE; Neuhaus J; Stolzenburg JU; Conaway MR; Mischak H; Theodorescu D
Clin Cancer Res; 2009 Aug; 15(15):4935-43. PubMed ID: 19602546
[TBL] [Abstract][Full Text] [Related]
4. Micropapillary urothelial carcinoma in a renal transplant recipient: a case report on urine cytomorphology emphasizing differentiation from high-grade urothelial carcinoma.
Seo KJ; Shin OR; Lee JY; Choi YJ
Cytopathology; 2015 Aug; 26(4):264-6. PubMed ID: 25123813
[No Abstract] [Full Text] [Related]
5. The molecular signature for urothelial carcinoma of the upper urinary tract.
Ho CL; Tzai TS; Chen JC; Tsai HW; Cheng HL; Eisenberger CF; Chow NH
J Urol; 2008 Mar; 179(3):1155-9. PubMed ID: 18206169
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma.
Downes MR; Torlakovic EE; Aldaoud N; Zlotta AR; Evans AJ; van der Kwast TH
J Clin Pathol; 2013 Sep; 66(9):779-86. PubMed ID: 23775437
[TBL] [Abstract][Full Text] [Related]
7. Histologic grading of urothelial carcinoma: a reappraisal.
Cheng L; MacLennan GT; Lopez-Beltran A
Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic difficulties in cases of papillary urothelial neoplasm of low malignant potential, urothelial proliferation of uncertain malignant potential, urothelial dysplasia and urothelial papilloma: A review of current literature.
Jaworski D; Szylberg Ł; Gzil A; Stawinski P; Kasperska A; Marszałek A
Ann Diagn Pathol; 2019 Jun; 40():182-188. PubMed ID: 29395466
[TBL] [Abstract][Full Text] [Related]
9. Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma.
Luo B; Li W; Deng CH; Zheng FF; Sun XZ; Wang DH; Dai YP
Cancer Genet Cytogenet; 2009 Mar; 189(2):93-7. PubMed ID: 19215789
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
11. Genitourinary cytopathology (kidney and urinary tract).
Barkan GA; Wojcik EM
Cancer Treat Res; 2014; 160():149-83. PubMed ID: 24092370
[TBL] [Abstract][Full Text] [Related]
12. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic, staging, and grading of urothelial carcinomas from urine: performance of BCA-1, a mini-array comparative genomic hybridisation-based test.
Larré S; Camparo P; Comperat E; Gil Diez De Medina S; Traxer O; Roupret M; Sebe P; Cancel-Tassin G; Sighar K; Lozach F; Cussenot O
Eur Urol; 2011 Feb; 59(2):250-7. PubMed ID: 21056532
[TBL] [Abstract][Full Text] [Related]
14. Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications.
Cheng L; Neumann RM; Bostwick DG
Cancer; 1999 Nov; 86(10):2102-8. PubMed ID: 10570438
[TBL] [Abstract][Full Text] [Related]
15. Malignant lymphoma case with urinary cytology mimicking that of urothelial carcinoma.
Takahashi H; Shimazaki H; Oda T; Endo H; Sekitsuka H; Maekawa K; Katsurada Y; Sato K; Ito K; Nakanishi K; Tamai S
Cytopathology; 2013 Dec; 24(6):412-4. PubMed ID: 23078009
[No Abstract] [Full Text] [Related]
16. The many faces of urothelial carcinoma: an update with an emphasis on recently described variants.
Nigwekar P; Amin MB
Adv Anat Pathol; 2008 Jul; 15(4):218-33. PubMed ID: 18580098
[TBL] [Abstract][Full Text] [Related]
17. Urinary basic fetoprotein in the diagnosis and follow-up of patients with urothelial carcinoma.
Kigure T; Wakayama Y; Satoh Y; Fujieda N; Yoshida K; Harada T
Cancer; 1996 Apr; 77(8):1529-34. PubMed ID: 8608539
[TBL] [Abstract][Full Text] [Related]
18. Imaging features of helical computed tomography suggesting advanced urothelial carcinoma arising from the pelvocalyceal system.
Kwak KW; Park BK; Kim CK; Lee HM; Choi HY
Acta Radiol; 2008 Feb; 49(1):121-6. PubMed ID: 18210321
[TBL] [Abstract][Full Text] [Related]
19. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
[TBL] [Abstract][Full Text] [Related]
20. Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine.
van Rhijn BW; Lurkin I; Chopin DK; Kirkels WJ; Thiery JP; van der Kwast TH; Radvanyi F; Zwarthoff EC
Clin Cancer Res; 2003 Jan; 9(1):257-63. PubMed ID: 12538478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
